{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:40:17Z","timestamp":1793356817092,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.euros.2026.09.008","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:31:59Z","timestamp":1791660719000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rapid Clearance of microRNA-371a-3p: A Longitudinal Study of Serum Levels in Patients with Localized Testicular Germ Cell Tumors"],"prefix":"10.1016","volume":"94","author":[{"given":"Klaus-Peter","family":"Dieckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Niemzok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Diesend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattis","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Klemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"W\u00fclfing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8613-3450","authenticated-orcid":false,"given":"Gazanfer","family":"Belge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.09.008_b0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1309\/AJCPOE11KEYZCJHT","article-title":"Identification of microRNAs from the miR-371\u223c373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors","volume":"135","author":"Murray","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.euros.2026.09.008_b0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.eururo.2021.06.006","article-title":"Circulating microRNAs, the next-generation serum biomarkers in testicular germ cell tumours: a systematic review","volume":"80","author":"Le\u00e3o","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.008_b0015","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/cancers16071379","article-title":"Advancing GCT management: a review of miR-371a-3p and other miRNAs in comparison to traditional serum tumor markers","volume":"16","author":"Seales","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"Suppl.","key":"10.1016\/j.euros.2026.09.008_b0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/1097-0142(19870801)60:3+<464::AID-CNCR2820601506>3.0.CO;2-C","article-title":"Biological markers in urologic cancer","volume":"60","author":"Lange","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2026.09.008_b0025","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.18.01480","article-title":"Serum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study","volume":"37","author":"Dieckmann","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2026.09.008_b0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/JU.0000000000001337","article-title":"Real-world application of pre-orchiectomy miR-371a-3p test in testicular germ cell tumor management","volume":"205","author":"Badia","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.09.008_b0035","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.18.02057","article-title":"Developing a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrum","volume":"37","author":"Nappi","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2026.09.008_b0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00432-020-03429-x","article-title":"Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin","volume":"147","author":"Belge","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.euros.2026.09.008_b0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00432-025-06101-4","article-title":"Biomarker microRNA-371a-3p - expression in malignancies other than germ-cell tumours","volume":"151","author":"Belge","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.euros.2026.09.008_b0050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/1078-0432.CCR-23-0730","article-title":"Detection of recurrence through microRNA-371a-3p serum levels in a follow-up of stage I testicular germ cell tumors in the DRKS-00019223 study","volume":"30","author":"Belge","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euros.2026.09.008_b0055","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41416-021-01643-z","article-title":"Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours","volume":"126","author":"Fankhauser","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euros.2026.09.008_b0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/bjc.2015.429","article-title":"A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours","volume":"114","author":"Murray","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euros.2026.09.008_b0065","doi-asserted-by":"crossref","first-page":"15582","DOI":"10.1038\/s41598-021-94812-2","article-title":"Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study","volume":"11","author":"Myklebust","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.euros.2026.09.008_b0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.path.2024.08.003","article-title":"Current role of microRNAs in the diagnosis and clinical management of germ cell tumors","volume":"18","author":"Tavares","year":"2025","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.euros.2026.09.008_b0075","doi-asserted-by":"crossref","first-page":"58037","DOI":"10.18632\/oncotarget.10867","article-title":"Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)","volume":"8","author":"van Agthoven","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.euros.2026.09.008_b0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.juro.2014.07.010","article-title":"Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer","volume":"193","author":"Syring","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.09.008_b0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/pathophysiology32040054","article-title":"MicroRNA-371a-3p represents a novel and effective diagnostic marker for testicular germ cell tumours: a real-world prospective comparison with conventional approaches","volume":"32","author":"Palermo","year":"2025","journal-title":"Pathophysiology"},{"key":"10.1016\/j.euros.2026.09.008_b0090","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000488771","article-title":"The novel biomarker of germ cell tumours, micro-RNA-371a-3p, has a very rapid decay in patients with clinical Stage 1","volume":"100","author":"Radtke","year":"2018","journal-title":"Urol Int"},{"key":"10.1016\/j.euros.2026.09.008_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2024.08.003","article-title":"Perioperative serum microRNA 371a-3p and 372-3p levels in patients with clinically localized testicular masses","volume":"68","author":"Matulewicz","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.09.008_b0100","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.2009.26.4481","article-title":"American Society of Clinical Oncology clinical practice guideline on uses of serum tumor markers in adult males with germ cell tumors","volume":"28","author":"Gilligan","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2026.09.008_b0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/14737159.2023.2206956","article-title":"A stroll through the present and future of testicular germ cell tumour biomarkers","volume":"23","author":"Tavares","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.euros.2026.09.008_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5030349","article-title":"Serum tumour markers in testicular germ cell tumours: frequencies of elevated levels and extents of marker elevation are significantly associated with clinical parameters and with response to treatment","volume":"2019","author":"Dieckmann","year":"2019","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.euros.2026.09.008_b0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.eururo.2023.04.010","article-title":"European Association of Urology guidelines on testicular cancer: 2023 update","volume":"84","author":"Patrikidou","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.008_b0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000510407","article-title":"Management of germ cell tumours of the testis in adult patients. German clinical practice guideline Part I: Epidemiology, classification, diagnosis, prognosis, fertility preservation, and treatment recommendations for localized stages","volume":"105","author":"Kliesch","year":"2021","journal-title":"Urol Int"},{"key":"10.1016\/j.euros.2026.09.008_b0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.euros.2026.09.008_b0130","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1007\/s00432-023-04664-8","article-title":"Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis","volume":"149","author":"Dieckmann","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.euros.2026.09.008_b0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.2047-2927.2014.00269.x","article-title":"MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker","volume":"3","author":"Spiekermann","year":"2015","journal-title":"Andrology"},{"key":"10.1016\/j.euros.2026.09.008_b0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2016.07.029","article-title":"Serum levels of microRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours","volume":"71","author":"Dieckmann","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.008_b0145","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1038\/s41598-023-37271-1","article-title":"Refining the serum miR-371a-3p test for viable germ cell tumor detection","volume":"13","author":"Lafin","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.euros.2026.09.008_b0150","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0338","article-title":"Germ cell tumour subtypes display differential expression of microRNA371a-3p","volume":"373","author":"Vilela-Salgueiro","year":"2018","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.euros.2026.09.008_b0155","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/jcmm.14013","article-title":"Clinical utility of plasma miR-371a-3p in germ cell tumors","volume":"23","author":"Mego","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.euros.2026.09.008_b0160","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/cancers12030759","article-title":"Evaluation of circulating miRNA biomarkers of testicular germ cell tumors during therapy and follow-up-a Copenhagen experience","volume":"12","author":"M\u00f8rup","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832603346X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832603346X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:03:58Z","timestamp":1793354638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266616832603346X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S266616832603346X"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.09.008","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid Clearance of microRNA-371a-3p: A Longitudinal Study of Serum Levels in Patients with Localized Testicular Germ Cell Tumors","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}